Astellas exploring selling Europe assets for $500m

Bloomberg yesterday evening reported that Japan-based Astellas Pharma is exploring selling its Central and Eastern Europe assets, worth at least $500m. Astellas’ management has already hired Jefferies Financial investment banking firm to look for a buyer. According to the report, some private equities and pharmaceutical companies have already expressed interest in the assets. Astellas’ shares today have increased 5% (+27% YTD) reaching JY3600bn ($32bn) in capitalization (Tokyo).

(Source: Bloomberg)